IRIS
BENNETT, DAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.750
NA - Nord America 7.002
AS - Asia 2.791
SA - Sud America 501
AF - Africa 70
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.875
IT - Italia 2.028
RU - Federazione Russa 1.785
GB - Regno Unito 1.275
SG - Singapore 935
CN - Cina 919
IE - Irlanda 904
BR - Brasile 435
DE - Germania 419
SE - Svezia 364
HK - Hong Kong 271
FR - Francia 245
UA - Ucraina 227
FI - Finlandia 204
VN - Vietnam 164
IN - India 115
KR - Corea 114
CA - Canada 77
ES - Italia 63
TR - Turchia 51
CZ - Repubblica Ceca 45
PL - Polonia 39
NL - Olanda 38
BD - Bangladesh 37
JP - Giappone 35
MX - Messico 32
AR - Argentina 25
CI - Costa d'Avorio 24
AT - Austria 22
BE - Belgio 21
ZA - Sudafrica 20
IQ - Iraq 19
IR - Iran 16
MA - Marocco 14
AU - Australia 13
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EC - Ecuador 10
ID - Indonesia 10
LT - Lituania 10
AZ - Azerbaigian 9
PH - Filippine 9
CH - Svizzera 8
PK - Pakistan 8
SA - Arabia Saudita 8
IL - Israele 7
KZ - Kazakistan 7
MK - Macedonia 7
PE - Perù 7
VE - Venezuela 7
GR - Grecia 6
JM - Giamaica 6
DK - Danimarca 5
EG - Egitto 5
JO - Giordania 5
PT - Portogallo 5
RO - Romania 5
UY - Uruguay 5
BO - Bolivia 4
HU - Ungheria 4
KG - Kirghizistan 4
CO - Colombia 3
CY - Cipro 3
EU - Europa 3
LK - Sri Lanka 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
GD - Grenada 2
HN - Honduras 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 18.119
Salva come PNG Salva come JPEG
Città #
Dallas 1.401
Southend 1.108
Dublin 888
Singapore 612
Fairfield 578
Moscow 526
Ashburn 525
Chandler 442
Santa Clara 387
Siena 284
Beijing 282
Hong Kong 262
Woodbridge 254
Seattle 215
Wilmington 208
Ann Arbor 200
Cambridge 183
Jacksonville 179
Houston 177
Milan 173
Munich 165
Hefei 150
New York 141
Los Angeles 126
Florence 121
Princeton 120
Seoul 112
Helsinki 109
Boardman 58
Rome 58
Dearborn 54
Nanjing 53
Buffalo 50
Dong Ket 50
Turku 47
Chicago 46
Shanghai 44
Fremont 42
London 42
Málaga 42
The Dalles 39
São Paulo 38
Ho Chi Minh City 37
San Mateo 37
Catania 35
Nuremberg 34
Tokyo 34
Warsaw 32
Bengaluru 28
Menlo Park 26
San Diego 26
Abidjan 24
Hanoi 24
Izmir 24
Brno 23
Düsseldorf 23
Frankfurt am Main 22
Toronto 22
Atlanta 21
Brussels 21
Lauterbourg 21
Denver 20
Montreal 20
Nanchang 20
Washington 20
Chennai 19
Columbus 19
Olomouc 19
Redondo Beach 19
Council Bluffs 18
Guangzhou 18
Lastra a Signa 18
Poplar 18
San Francisco 18
Shenyang 18
Gavirate 17
Brooklyn 16
Changsha 16
Lappeenranta 16
Padova 16
Phoenix 16
Johannesburg 15
Mumbai 15
Hebei 14
Boston 13
Brescia 13
Norwalk 13
Trieste 13
Messina 12
Orem 12
Paris 12
Portsmouth 12
Arezzo 11
Clifton 11
Jiaxing 11
Mexico City 11
Miami 11
Stockholm 11
Comun Nuovo 10
Dhaka 10
Totale 11.696
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.025
A first update on mapping the human genetic architecture of COVID-19 537
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 355
Antirheumatic agents in covid-19: is IL-6 the right target? 330
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 328
An explainable model of host genetic interactions linked to COVID-19 severity 324
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 317
Peripheral biomarkers' panel for severe COVID-19 patients 290
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 282
Exhaled nitric oxide in interstitial lung diseases 252
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 248
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 247
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 245
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 245
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 241
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 240
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 236
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 233
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 232
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 230
Bronchial stenosis following lung transplant: An innovative approach with a modified endobronchial emphysema valve 226
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 225
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 221
Serum amyloid A in patients with idiopathic pulmonary fibrosis 221
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 219
Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? 218
Prognostic bioindicators in severe COVID-19 patients 217
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 212
Serial KL-6 measurements in COVID-19 patients 211
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 209
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 200
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 199
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 196
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 192
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 192
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 191
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 189
SARS-CoV-2 in pleural fluid in a kidney transplant patient 189
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 186
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 185
Extracorporeal Photopheresis in Lung Transplantation 185
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 184
WES profiling of COVID-19 182
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 179
Biomarkers in sarcoidosis: The contribution of system biology 179
Proteomic investigation of pulmonary sarcoidosis 178
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 176
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 175
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 175
IPF mortality in waiting list for lung transplantation 171
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 169
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 166
null 165
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 165
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 163
Chitotriosidase: a sensitive biomarker of sarcoidosis 162
BIOMARKERS WITH CLINICAL SIGNIFICANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASES 161
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 161
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 156
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study 156
Familial pulmonary fibrosis: Clinical-functional and radiological features 155
New concepts in the pathogenesis of sarcoidosis 155
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 149
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 149
Timing of Osteoporotic Vertebral Fractures in Lung and Heart Transplantation: A Longitudinal Study 147
null 145
IPFdatabase - A new tool for a correct application of idiopathic pulmonaty fibrosis guidelines 144
Whole-genome sequencing reveals host factors underlying critical COVID-19 143
Rischio infettivo nel trapianto di polmone per fibrosi polmonare: analisi retrospettiva 143
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis 142
Outcome of ECMO bridge to lung transplantation: a single cohort study 137
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 134
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 133
The Role of Galectins in Chronic Lung Allograft Dysfunction 131
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 128
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 127
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 122
null 121
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 119
Incidenza e fattori di rischio per colonizzazione ed infezione respiratoria batterica a 30 giorni in pazienti trapiantati di polmone 116
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 115
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 114
Cavernous sinus syndrome due to neurosarcoidosis in adolescence: a diagnosis not to be missed 111
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 109
null 106
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 103
Donor-Recipient Mismatch in Lung Transplantation: The Role of Graft Sizing in Clinical Outcomes 95
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 95
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 95
NK and T cells responses to CMV in patients awaiting for lung transplantation 93
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 90
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 89
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 81
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 81
Lung transplantation in patients with previous or unknown oncological disease: evaluation of short- and long-term outcomes 77
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study 72
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 67
Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis 47
A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis 44
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 37
Totale 18.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.040 0 0 0 0 0 194 104 201 138 148 132 123
2021/20221.230 93 153 86 97 71 47 57 72 50 118 146 240
2022/20231.799 145 187 195 225 152 266 157 151 154 74 57 36
2023/20241.752 76 49 179 89 80 408 532 67 15 48 51 158
2024/20253.150 108 161 417 152 371 198 169 164 199 139 355 717
2025/20265.515 553 993 1.186 1.053 1.687 43 0 0 0 0 0 0
Totale 18.484